Recruitment target and sites

Find out the trial target recruitment and which sites are recruiting

Recruitment

Deep Immunophenotyping Group: Target 150 patients in each cohort

  • Rheumatic/Inflammatory conditions
  • Cancer
  • Chronic liver conditions and inflammatory bowel disease
  • Chronic renal conditions
  • Haematopoietic stem cell transplant (HSCT) and chimeric antigen receptor (CAR) T cell recipients
  • Rheumatic, liver and renal conditions are closed

Serology Group: 850 patients in each cohort

  • Rheumatic/Inflammatory conditions
  • Cancer
  • Chronic liver conditions and inflammatory bowel disease
  • Chronic renal conditions
  • Haematopoietic stem cell transplant (HSCT) and chimeric antigen receptor (CAR) T cell recipients
  • Renal conditions is closed

Participating sites

Principal Investigators and their main associated site
 Site Name Principal Investigator
 Addenbrooke’s Hospital, Cambridge  Dr Ram Malladi
 Glasgow Royal Infirmary, Glasgow  Professor Stefan Siebert
 Hammersmith Hospital, London  Dr Michelle Willicombe & Dr David Thomas
 John Radcliffe Hospital, Oxford  Professor Eleanor Barnes
 King’s College Hospital, London  Dr Robin Sanderson
 Queen Elizabeth Hospital, Birmingham  Professor Daniel Rea
 Royal Hallamshire Hospital, Sheffield   Professor John Snowden
 Southampton General Hospital, Southampton       Dr Kim Orchard
 St James’s University Hospital, Leeds     Professor Gordon Crook

Participant Identification Centres (PIC)

  • Royal Berkshire NHS Foundation Trust
  • Milton Keynes University Hospital NHS Foundation Trust